Central and peripheral hemodynamic effects of angiotensin inhibition in patients with refractory congestive heart failure.
D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007866:Leg / Q000098:blood supply; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D009842:Oligopeptides / Q000627:therapeutic use*; D011652:Pulmonary Circulation / Q000187:drug effects; D012083:Renin / Q000097:blood; D013722:Teprotide / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects
D000806:Angiotensin-Converting Enzyme Inhibitors; D009842:Oligopeptides; D013722:Teprotide; D012083:Renin; D009638:Norepinephrine